Your SlideShare is downloading. ×
Get more info on this report!Healthcare in a Recession (OTC, Generics, Out of Pocket Spending,Healthcare Legislation, Reta...
Care Credit    Cerner Corporation    Credit Medical    CSI Financial Services    E- Financing Solutions    GlaxoSmithKline...
Overview THE NEED FOR ALTERNATIVES     High Cost of Care     Healthcare ReformCHAPTER THREE: OUT-OF-POCKET EXPENDITURES: T...
Motivations for Medical Tourism     Impact of Recession     True Medical Tourism vs. All Healthcare for ForeignersCHAPTER ...
Credit MedicalCSI Financial ServicesE- Financing SolutionsGlaxoSmithKlineHistory and Lines of BusinessStrategic AlliancesV...
Wal - MartLIST OF EXHIBITS CHAPTER TWO: INTRODUCTION     Figure 2-1:National Health Expenditures (NHE) and NHE as a Percen...
Table 4-5: Consumer Out-of-pocket Expenditures by Type, 2001-2011     Figure 4-2: Proportion of Consumer Out-of-pocket Spe...
CHAPTER ELEVEN: IMPACT OF HEALTHCARE LEGISLATION       Table 11-1: Likely Impact of Events and Proposed Legislation (Props...
Upcoming SlideShare
Loading in...5
×

Healthcare in a recession (otc, generics, out of pocket spending, healthcare legislation, retail clinics, outsourcing and other topics)

167

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
167
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Healthcare in a recession (otc, generics, out of pocket spending, healthcare legislation, retail clinics, outsourcing and other topics)"

  1. 1. Get more info on this report!Healthcare in a Recession (OTC, Generics, Out of Pocket Spending,Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)April 1, 2009Current economic conditions dominate business strategies. While healthcare has faredbetter than other industries, it will not be immune from the effects of the currentrecession. But what aspects of healthcare will be impacted? How much of spending willbe out of the consumers pocket? How will some novel trends (retail clinics, medicaltourism) fit into this economy? It is commonly asserted that OTC and generic drugssales will be boosted. Will this pan out? What will be the possible effects of varioustypes of healthcare plans that might be implemented?In Healthcare in a Recession,Kalorama Information has examined all of the key medicalmarkets in the past and has witnessed change and in some sectors profits due toeconomic conditions. Kalorama has consulted its experts in key areas and asked aboutthe effect of the recession. This report takes a broad look at the healthcare market in arecession from the many areas of healthcare that have changed or will changed.Specifically the report address: The State of the Pharmaceutical Industry Outsourcing and Offshoring Generic Drugs: A Coming Boom? Over the Counter Drugs Possible impact of Healthcare Legislation Out of Pocket Healthcare Spending: Current and Future The Retail Clinic Phenomenon Availability of Health Insurance Medical Tourism: Boom or Bust? Influential PharmacistsAs part of its research, Kalorama has profiled and detailed the activities of severalcompanies in the pharmaceutical, retail, healthcare financing and informationtechnology fields that likely to play some role in the healthcare economy of 2009: APFUSA Atlantic Care Aurora Quick Care Capitol One Healthcare Finance
  2. 2. Care Credit Cerner Corporation Credit Medical CSI Financial Services E- Financing Solutions GlaxoSmithKline Hospira Inc. Med Basics McKesson Corporation Medco Health Solutions, Inc. Merck & Co. Inc Med choice Financial MedDirect Minute Clinic Novartis My Healthy Access Now Medical Centers PFS Quick Health Rediclinic Reliance Medical Finance Solantic Take Care Health Systems Target Clinic Medical Associates TEVA Pharmaceutical Industries, Ltd. Wyeth (Pfizer) Siemens Medical Solutions Wal - MartTABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY Out of Pocket Spending Healthcare Legislation State of the Pharmaceutical Industry, 2009 • Meeting Investor Expectations • Erosion of Blockbuster Sales • Increased Generic Competition • Pricing Pressures • Pipeline Output Slowing Compared to ROI • Mergers &Aquisitions Retail Clinics OTC/Generic DrugsCHAPTER TWO: INTRODUCTION The U.S. Healthcare System Today
  3. 3. Overview THE NEED FOR ALTERNATIVES High Cost of Care Healthcare ReformCHAPTER THREE: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2009 Types of Expenditures Insurance Co-Payments Direct Payments Premiums and Plan Fees Cash or Check Credit Cards Loans and Lines of Credit Flexible Spending Accounts Health Savings Accounts Medical Financing Elective Procedures Non-Elective Procedures and Prescription Drugs Consumers Who Pay Out Of Pocket The Uninsured and Underinsured Medicaid Recipients The Disabled Senior Citizens The Mentally Ill The Obese Persons with Chronic ConditionsCHAPTER FOUR: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2009 - 2013 Out-of-pocket Expenditure Growth Drivers Payment Methods Consumers Who Pay Out-of-pocketCHAPTER FIVE: OVER THE COUNTER DRUGS: IN POSITION United States Market OTC and Recession: Avoiding the Copay Behind the Counter Drugs?CHAPTER SIX: INFLUENTIAL PHARMACISTS Markets - Pharmacists Impact The Prescribing Pharmacist Main Drivers For Increased Pharmacist Prescription AuthorityCHAPTER SEVEN: MEDICAL TOURISM: BOOM OR BUST?
  4. 4. Motivations for Medical Tourism Impact of Recession True Medical Tourism vs. All Healthcare for ForeignersCHAPTER EIGHT: STATE OF THE PHARMACEUTICAL MARKET: OFFSHORINGAND OUTSOURCING Meeting Investor Expectations Erosion of Blockbuster Sales Increased Generic Competition Pricing Pressures Pipeline Output Slowing Compared to ROI M&A Offshoring Clinical Trials Size and Growth of the Market Outsourcing: No Longer Optional For Pharma Strategic Outsourcing Outsourcing Manufacturing OperationsCHAPTER NINE: GENERIC DRUGS: COMING BOOM? Overview Issues in GenericsCHAPTER TEN: RETAIL CLINICS Retail Clinics Business Competition with Primary Care Providers RegulationCHAPTER ELEVEN: IMPACT OF HEALTHCARE LEGISLATION Overview Change for Pharma Focus on Cost - Cutting Healthcare ReformCHAPTER TWELVE: COMPANY PROFILES APFUSA Atlantic Care Aurora Quick Care Capitol One Healthcare Finance Care Credit Cerner Corporation Products and Service Key Competitors
  5. 5. Credit MedicalCSI Financial ServicesE- Financing SolutionsGlaxoSmithKlineHistory and Lines of BusinessStrategic AlliancesVaccine ProductsOTC ProductsFinancial InformationHospira Inc.Med BasicsMcKesson CorporationCompany OverviewProducts and ServiceMedco Health Solutions, Inc.Merck & Co. IncHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationMed choice FinancialMedDirectMinute ClinicNovartisHistory and Lines of BusinessStrategic AlliancesVaccine ProductsMy Healthy AccessNow Medical CentersPfsQuick HealthRediclinicReliance Medical FinanceSolanticTake Care Health SystemsTarget Clinic Medical AssociatesTEVA Pharmaceutical Industries, Ltd.Wyeth (Pfizer)History and Lines of BusinessVaccine ProductsOTC ProductsFinancial InformationSiemens Medical SolutionsKey CompetitorsGrowth StrategyLocations
  6. 6. Wal - MartLIST OF EXHIBITS CHAPTER TWO: INTRODUCTION Figure 2-1:National Health Expenditures (NHE) and NHE as a Percent of GDP, 1980 - 2013 Figure 2-2: Unnecessary Deaths Resulting From Variations in Health Care Quality, by Condition (Prenatal Care, Diabetes Care, Beta Blocker Treatment, Breast Cancer Screening, Cholesterol Management, High Blood Pressure, Diabetes) Figure 2-3:HEDIS Scores by Quality of Health Care Plan, 2008 Table 2-1: U.S. Health Care Coverage by State, 2008CHAPTER THREE: OUT-OF-POCKET EXPENDITURES THE MARKET IN 2009 Figure 3-1:Premium Increases vs. Increases in Workers Earnings and Prices, 1989 - 2008 Figure 3-2: Consumer Out-of-pocket Health Care Expenditures, Figure 3-3:Consumer Out-of-pocket Health Care Expenditures by Payment Type,2008 Table 3-1: Credit Card Debt of Consumers With Medical Debt, 2007 Table 3-2: Credit Card Debt of Consumers With Medical Debt, 2007 Table 3-3: Main Business Activities of Selected Medical Financing Companies, Figure 3-4:by Percentile of Total Health Spending, Figure 3-5:Methods of Financing Elective Procedures, Figure 3-6: Average Share Paid Out-of-pocket by U.S. Residents with Health Care Spending by Type of Service, 2008 Figure 3-7: by Percentile of Total Health Spending and Type of Service, 2008 Figure 3-8: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2008 Figure 3-9: Distribution of Out-of-pocket Spending for the Average Person, by Spending Level, 2008 Figure 3-10: Drug Cost Coverage by Payor Type (Public, Private, Cash) 1965, 1986, 2000, 2004, 2008 Table 3-4: Obesity in the United States, 1980 - 2013 Figure 3-11: Proportion of Adults Under Age 65 With Chronic Conditions, 2008CHAPTER FOUR: FORECASTED OUT-OF-POCKET EXPENDITURES: THE MARKETIN 2009 - 2013 Table 4-1: Selected Rx-to-OTC Switches in the United States, 1990 - Present Table 4-2: Rx-to-OTC Switch Candidates in the United States, 2009 - 2013 Table 4-3: Consumer Out-of-pocket Expenditures per Worker 2003-2013 (in $) Table 4-4: Consumer Out-of-pocket Expenditures by Type, 2003-2013 Figure 4-1: Proportion of Consumer Out-of-pocket Spending by Type of Health Care Expenditure
  7. 7. Table 4-5: Consumer Out-of-pocket Expenditures by Type, 2001-2011 Figure 4-2: Proportion of Consumer Out-of-pocket Spending by Payment Type, 2003, 2008, 2013 Table 4-6: Amount of Consumer Out-of-pocket Expenditures for Elective Procedures That Are Financed, 2003-2013 Table 4-7: Amount of Consumer Out-of-pocket Expenditures for Non-Elective Procedures That Are Financed, 2001-2011 Figure 4-3: Proportion of Consumer Out-of-pocket Spending for Elective ProceduresThat is Financed (All Methods), Figure 4-4: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2008, 2013 Figure 4-5: Proportion of Consumer Out-of-pocket Spending for Non-Elective Procedures That is Financed (All Methods),2008 - 2013 Table 4-8: Size of High Risk Groups for High Out-of-pocket Health Care Expenditures, 2003-2013 (Millions of Persons)CHAPTER FIVE: OVER THE COUNTER DRUGS: IN POSITION Table 5-1: Projected US OTC Revenues 2008-2012CHAPTER SIX: INFLUENTIAL PHARMACISTS Figure 6-1: Declining Drug Purchases Not Influenced By Pharmacists, 2006-2012 Table 6-1: Pharmacists Influence in Drug Selection and/or Therapy Aspect: 2007 and 2012 Table 6-2: States Likely to Implement Independent Prescribing FirstCHAPTER SEVEN: MEDICAL TOURISM: BOOM OR BUST? Table 7-1: Cost Savings From Medical Tourism For Various Procedures, 2008 Figure 7-1: US ‘True Medical Tourism’ Revenues, 2008, 2010CHAPTER EIGHT: STATE OF THE PHARMACEUTICAL MARKET,: OFFSHORINGAND OUTSOURCING Table 8-1: Clinical Trial Market in Select Countries 2006-2012 Table 8-2: Global Prescription Pharmaceutical Contract Manufacturing Market Primary, Secondary and Biomanufacturing 2003-2013CHAPTER NINE: GENERIC DRUGS: COMING BOOM? Table 9-1: US Generic Drug Market 2008-2012CHAPTER TEN: RETAIL CLINICS Figure 10-1: Growth of U.S. Retail Clinic Services
  8. 8. CHAPTER ELEVEN: IMPACT OF HEALTHCARE LEGISLATION Table 11-1: Likely Impact of Events and Proposed Legislation (Propsed Change, Probability, Positive Impact, Negative Impact)Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2123096US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004

×